UBS Group
RND

UBS Group’s First Trust Bloomberg R&D Leaders ETF RND Stock Holding History

UBS Group’s Portfolio RND Stock Details RND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$122 – 11325
2025
Q4 		$122 Sell
4
-124
-97% -$3.75K ﹤0.01% 10162
2025
Q3 		$3.79K Buy
+128
New +$3.6K ﹤0.01% 9011

Other funds holding RND

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CWM
Concentrum Wealth Management San Jose, California $339M AUM 26.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's RND Position: Q1 2026 in Review

UBS Group sold out of First Trust Bloomberg R&D Leaders ETF (RND) in Q1 2026, closing a stake of 4 shares — an estimated $122 sold.

UBS Group first reported a position in RND in Q3 2025 and held it in 2 quarters. The position peaked at $3.79K in Q3 2025. 3 funds tracked by Wall St. Rank hold RND as of Q1 2026.

  • UBS Group reported no remaining First Trust Bloomberg R&D Leaders ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 4 First Trust Bloomberg R&D Leaders ETF shares in Q1 2026, an estimated $122.
  • UBS Group first reported a position in First Trust Bloomberg R&D Leaders ETF in Q3 2025 and held it in 2 quarters.
  • UBS Group's First Trust Bloomberg R&D Leaders ETF position peaked at $3.79K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held First Trust Bloomberg R&D Leaders ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.